Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17.
CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release.
The authorization includes those 12 and up based on modeling that shows it would have similar effects in children as in adults if they were a certain weight, but Pfizer said in its release that the data from the new trial"will provide further support for the dose recommendations in this population, as well as potentially expand the indication to younger age groups and lower weights."
"There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death," said Dr. Mikael Dolsten, Pfizer's chief scientific officer and president of worldwide research, development and medical, in the release.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Phase 2, 3 trial for Pfizer pill for COVID begins in children ages 6 to 17'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
Read more »
Phase 2, 3 trial for Pfizer pill for COVID begins in children ages 6 to 17'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
Read more »
Pfizer Starts Testing Its Covid-19 Pill in ChildrenPfizer expects results from its study of the Covid-19 drug Paxlovid in high-risk children by the end of the year
Read more »
Most Side Effects From Pfizer, Moderna Covid Shots Are Mild And Short-Lived, Major Study FindsI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Read more »
Jared Kushner key to doubling vaccines for US: Pfizer CEOFormer White House adviser and top Trump negotiator Jared Kushner played the key role in doubling the number of Pfizer vaccine doses the firm initially set aside for Americans, a move that may have helped slow the coronavirus spread much faster, according to a new book.
Read more »